ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knight, J.
Right arrow Articles by Blaylock, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, J.
Right arrow Articles by Blaylock, R.
Annals of Clinical and Laboratory Science, Vol 23, Issue 3, 178-183
Copyright © 1993 by Association of Clinical Scientists


Articles

Lipid peroxidation compared in stored whole blood with various nutrient-anticoagulant solutions

JA Knight, DA Searles, and RC Blaylock

Since the introduction of acid-citrate-dextrose (ACD) in 1947 to anticoagulate and preserve whole blood for transfusion, various improved formulas, such as citrate-phosphate-dextrose-adenine (CPDA-1), have been successfully introduced, extending the current acceptable blood storage time to 35 days. Additional nutrient-anticoagulant solutions, including CPDA-2, CPDA-3, AS-1, and AS-5, among others, have more recently been studied with comparable results. In this study, lipid peroxidation (LP) was compared, as determined by the measurement of plasma malondialdehyde (MDA) by liquid chromatography, in stored blood preserved with various nutrient solutions with blood treated with CPDA-1. Although minor but inconsistent differences were noted with most of these solutions compared with CPDA-1, AS-1 gave consistently lower MDA levels (P < 0.01). Further improvements in red cell storage and viability may require approaches other than nutrient formula variations, such as the addition of metal chelating agents or other selected antioxidants to the nutrient-anticoagulant solutions, donor supplementation with vitamin free radical scavengers, or other as yet undetermined conditions.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association of Clinical Scientists.